Markets:

Overview

News

Currencies

International

Treasuries

Bionano Genomics, Inc. - Common Stock (NQ:BNGO)

1.680 +0.020 (+1.20%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 10, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bionano Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 29, 2022

Via Benzinga

7 Hot Growth Stocks Poised to Triple by 2030 ↗

August 25, 2022

For multiple reasons, this looks like a wonderful time for investors to buy hot growth stocks with very strong outlooks.

Via InvestorPlace

7 Cheap Penny Stocks to Buy Before They Boom ↗

August 19, 2022

If you have the stomach for extreme speculation, these cheap penny stocks to buy could move higher (but be ready for anything).

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 12, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

What In The World Is Going On With Bionano Genomics Shares? ↗

August 11, 2022

Bionano Genomics, Inc. (NASDAQ: BNGO) are trading higher by 11.8% to $3.36 Thursday afternoon. The company Thursday morning today announced the publication of the first study to evaluate the utility of...

Via Benzinga

Recap: Bionano Genomics Q2 Earnings ↗

August 04, 2022

Bionano Genomics (NASDAQ:BNGO) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Bionano Genomic (BNGO) Stock Pops on Research Study ↗

August 02, 2022

Bionano Genomic is in the news today as a landmark research focusing on genomic mapping technology bolsters BNGO stock.

Via InvestorPlace

Why Is Bionano Genomics (BNGO) Stock Up 20% Today? ↗

August 11, 2022

Bionano Genomics is in the news again, delivering groundbreaking nanoscale analytics research that has BNGO stock reaching for the stars.

Via InvestorPlace

Short Interest Sector Focus: Healthcare Sector ↗

July 29, 2022

As of the close of business on Thursday, 7/28, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...

Via Benzinga

The 7 Best Stocks to Buy on a Dip in July ↗

July 14, 2022

With the stock market pricing in a recession that likely won't arrive anytime soon, these are some of the best stocks to buy on a dip.

Via InvestorPlace

3 Stocks That Could Double in 2022 ↗

June 08, 2022

With the market shaking off its downturn and the economy strengthening, there are several stocks that could double before the year is out.

Via InvestorPlace

Looking Into Bionano Genomics's Return On Capital Employed ↗

May 27, 2022

Bionano Genomics (NASDAQ:BNGO) brought in sales totaling $5.70 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 30.52%, resulting in a loss of $29.95 million.

Via Benzinga

Hold On to Bionano Genomics Stock Until It Reaches $6 at Least ↗

March 08, 2022

After a year of blockbuster revenue growth, BNGO stock deserves a major re-rating

Via InvestorPlace

Earnings Scheduled For March 1, 2022 ↗

March 01, 2022

Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...

Via Benzinga

Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday ↗

August 11, 2022

Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.

Via Benzinga

7 Cheap Biotech Stocks to Buy Now ↗

May 19, 2022

These biotech stocks can be speculative, but have the potential to blow up in the next couple of years for good gains.

Via InvestorPlace

Bionano Genomics's Earnings Outlook ↗

May 04, 2022

Bionano Genomics (NASDAQ:BNGO) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Bionano...

Via Benzinga

The Latest Studies by Bionano Genomics Are Promising, But It’s Not a Buy Yet ↗

April 11, 2022

BNGO stock has provided positive news from study results lately, but its fundamentals are not great and not a reason to invest in it now.

Via InvestorPlace

Why Bionano Genomics Stock Is Risky, but a Good Bet ↗

April 01, 2022

The risks may be clear when it comes to Bionano Genomics and BNGO stock. However, investors should see this as a long-term play.

Via InvestorPlace

Bionano Genomics Stock Can Regain the Crucial $5 Level ↗

March 22, 2022

Bionano Genomics is working hard to address rare diseases, yet Wall Street doesn't see the value in BNGO stock -- but that could change soon.

Via InvestorPlace

Bionano Genomics May Finally Offer a Reward for Your Risk ↗

March 18, 2022

BNGO stock has been a falling knife for the past year. But, with promising fundamentals and good tailwinds, now be the time to take a chance.

Via InvestorPlace

Bionano Genomics's Return On Capital Employed Insights ↗

March 04, 2022

Benzinga Pro data, Bionano Genomics (NASDAQ:BNGO) reported Q4 sales of $6.30 million. Earnings fell to a loss of $22.95 million, resulting in a 10.58% decrease from last quarter...

Via Benzinga

Bionano Genomics's Earnings Outlook ↗

February 28, 2022

Bionano Genomics (NASDAQ:BNGO) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Bionano Genomics Has Attractive Applications But An Unattractive Stock Price ↗

February 24, 2022

BNGO stock will witness more hard times until profitability is improved and sales start to rebound. That could take some time.

Via InvestorPlace

Bionano Stock Looks to Have a Monster Comeback in Its Future ↗

February 17, 2022

Bionano's Saphyr appears to be able to help doctors treat leukemia, and the adoption of its device is growing rapidly.

Via InvestorPlace

Investors Have Cast Their ‘No’ Votes Against Bionano Genomics ↗

February 07, 2022

A preliminary report from Bionano Genomics doesn't tell the full story and a lack of profitability will likely weigh on BNGO stock.

Via InvestorPlace

Bionano Is Not the Genomics Stock To Bet On ↗

February 04, 2022

Bionano's recent results are lackluster and point to more volatility ahead for BNGO stock. Best to just avoid this stock for now.

Via InvestorPlace

Bionano Genomics Is Interesting as Genome Testing Scales Upwards ↗

January 25, 2022

BNGO Stock is a play in the burgeoning gene sequencing market at scale, not at home. That's worth understanding and potentially purchasing.

Via InvestorPlace

Bionano Genomics Preliminary Q4, FY21 Revenue Exceed Expectations ↗

January 12, 2022

Bionano Genomics Inc (NASDAQ: BNGO) posted preliminary Q4 sales of $5.8 million - $6.2 million, +25% - 33% sequentially, up 45% - 55% Y/Y, and above the consensus...

Via Benzinga

7 of the Best Cheap Stocks Under $10 for 2022 to Buy Now ↗

January 06, 2022

These cheap stocks under $10 are poised to rally in the new, more friendly macro environment that's in place as 2022 unfolds.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.